Home » Topics » Gastrointestinal, BioWorld Science

Gastrointestinal, BioWorld Science
RSS

Antiinflammatory agent by Uriach promising for the treatment of IBD

Oct. 7, 2004

Santarus launches Zegerid

Oct. 7, 2004

Pirfenidone effective against cirrhosis in vivo

Oct. 7, 2004

Novel anti-H. pylori agents designed by Kotobuki scientists

Oct. 7, 2004

Therapeutic effects of HepeX-B in patients with chronic HBV infection

Oct. 6, 2004

Entecavir submitted for U.S., European marketing approval for hepatitis B

Oct. 6, 2004

Novel anti-HCV agents targeting NS3-NS4A protease claimed by Enanta

Oct. 6, 2004

DA-9601 increases ghrelin, leptin in peptic ulcer models

Oct. 5, 2004

Gilead Sciences and Genelabs collaborate in HCV

Oct. 5, 2004

Oral tacrolimus shows promise in steroid-refractory ulcerative colitis

Oct. 5, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...
Next wave of BCI firms builds on pioneers to tackle challenges
BioWorld
With the pace of neurotechnology development accelerating, a wave of brain-computer interface (BCI) companies is emerging on the heels of the pioneers. In the...
Boehringer Ingelheim identifies new mGlu3 receptor agonists
BioWorld Science
Boehringer Ingelheim Pharma GmbH & Co. KG and Vanderbilt University have discovered new dihydrobenzoxazine compounds acting as metabotropic glutamate mGlu3...
GT-02897 exerts efficacy in preclinical multiple myeloma
BioWorld Science
Investigators from the Karl Landsteiner University aimed to evaluate the therapeutic potential of a novel CDK9 inhibitor/degrader, GT-02897, for the potential...